soybean agglutinin sba (Vector Laboratories)
Vector Laboratories is a verified supplier 
Vector Laboratories manufactures this product 
93
Structured Review
Vector Laboratories
soybean agglutinin sba
Soybean Agglutinin Sba, supplied by Vector Laboratories, used in various techniques. Bioz Stars score: 93/100, based on 84 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/L-1010/Unconjugated+Soybean+Agglutinin+(SBA)/10__3390_slash_biom16101404-50-10-16
Average 93 stars, based on 84 article reviews
Soybean Agglutinin Sba, supplied by Vector Laboratories, used in various techniques. Bioz Stars score: 93/100, based on 84 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/L-1010/Unconjugated+Soybean+Agglutinin+(SBA)/10__3390_slash_biom16101404-50-10-16
Average 93 stars, based on 84 article reviews
soybean agglutinin sba - by Bioz Stars,
2026-11
93/100 stars
Images
Related Articles
Methylation:Article Title: Alpha 1,3 N-Acetylgalactosaminyl Transferase (GTA) Impairs Invasion Potential of Trophoblast Cells in Preeclampsia Article Snippet: .. The following chemicals were used: Methylation inhibitor 5-AzaC (HY-10586, MCE, Rahway, NJ, USA); Matrigel (REF:354262, Corning, NY, USA); primary antibodies against CD31 (Cat No. 11265-1-AP), E-cadherin (Cat No. 20874-1-AP), N-cadherin (Cat No. 22018-1-AP), Vimentin (Cat No. 10366-1-AP), Snail (Cat No. 13099-1-AP), and GAPDH (Cat No. 10494-1-AP) (Proteintech, Wuhan, China); primary antibodies against PCNA (AF0261), Cyclin D1(AF0126), and Cyclin E2 (AF2494) (Beyotime, Shanghai, China); GTA antibody (LS-C482291, Life Span, Seattle, WA, USA); CD34 antibody (ab81289, Abcam, Cambridge, UK); VE-cadherin antibody (sc-515467, Santa Cruz, Dallas, TX, USA); and Article Title: Alpha 1,3 N-Acetylgalactosaminyl Transferase (GTA) Impairs Invasion Potential of Trophoblast Cells in Preeclampsia. Article Snippet: .. The following chemicals were used: Methylation inhibitor 5-AzaC (HY-10586, MCE, Rahway, NJ, USA); Matrigel (REF:354262, Corning, NY, USA); primary antibodies against CD31 (Cat No. 11265-1-AP), E-cadherin (Cat No. 20874-1-AP), N-cadherin (Cat No. 22018- 1-AP), Vimentin (Cat No. 10366-1-AP), Snail (Cat No. 13099-1-AP), and GAPDH (Cat No. 10494-1-AP) (Proteintech, Wuhan, China); primary antibodies against PCNA (AF0261), Cyclin D1(AF0126), and Cyclin E2 (AF2494) (Beyotime, Shanghai, China); GTA antibody (LS-C482291, Life Span, Seattle, WA, USA); CD34 antibody (ab81289, Abcam, Cambridge, UK); VE-cadherin antibody (sc-515467, Santa Cruz, Dallas, TX, USA); and Whole Genome Amplification:Article Title: A Redox-Switchable Supramolecular Carbohydrate Chip for Capture and Real-Time Glycosylation Analysis of Living Suspension Cells Article Snippet: Dopamine hydrochloride, concanavalin A (Con A), D-galactose, tris(hydroxymethyl)aminomethane (Tris) were purchased from Sigma-Aldrich (St. Louis, MO, USA). .. Wheat germ agglutinin (WGA), Ulex europaeus agglutinin I (UEA-I), and Article Title: Paracellular Delivery of Protein Drugs with Smart EnteroPatho Nanoparticles. Article Snippet: A general platform for the safe and effective oral delivery of biologics would revolutionize the administration of protein-based drugs, improving access for patients and lowering the financial burden on the health-care industry.. Because of their dimensions and physiochemical properties, nanomaterials stand as promising vehicles for navigating the complex and challenging environment in the gastrointestinal (GI) tract.. Recent developments have led to materials that protect protein drugs from degradation and enable controlled release in the small intestine, the site of absorption for most proteins. Glycoproteomics:Article Title: Paracellular Delivery of Protein Drugs with Smart EnteroPatho Nanoparticles. Article Snippet: A general platform for the safe and effective oral delivery of biologics would revolutionize the administration of protein-based drugs, improving access for patients and lowering the financial burden on the health-care industry.. Because of their dimensions and physiochemical properties, nanomaterials stand as promising vehicles for navigating the complex and challenging environment in the gastrointestinal (GI) tract.. Recent developments have led to materials that protect protein drugs from degradation and enable controlled release in the small intestine, the site of absorption for most proteins. |